↓ Skip to main content

Dove Medical Press

Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics

Overview of attention for article published in OncoTargets and therapy, November 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
9 Mendeley
Title
Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics
Published in
OncoTargets and therapy, November 2021
DOI 10.2147/ott.s273357
Pubmed ID
Authors

Matthew Z Guo, Kristen A Marrone, Alexander Spira, David M Waterhouse, Susan C Scott

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Other 1 11%
Student > Doctoral Student 1 11%
Student > Bachelor 1 11%
Student > Master 1 11%
Professor > Associate Professor 1 11%
Other 0 0%
Unknown 4 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 33%
Nursing and Health Professions 1 11%
Medicine and Dentistry 1 11%
Engineering 1 11%
Unknown 3 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2021.
All research outputs
#16,124,654
of 25,584,565 outputs
Outputs from OncoTargets and therapy
#875
of 2,967 outputs
Outputs of similar age
#231,387
of 444,384 outputs
Outputs of similar age from OncoTargets and therapy
#5
of 42 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,967 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,384 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.